Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2230209
Max Phase: Preclinical
Molecular Formula: C18H18FN3O4S2
Molecular Weight: 423.49
Molecule Type: Small molecule
Associated Items:
ID: ALA2230209
Max Phase: Preclinical
Molecular Formula: C18H18FN3O4S2
Molecular Weight: 423.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)/C=C/CSc1nc2cc(-n3nc(C(C)(C)C)oc3=O)c(F)cc2s1
Standard InChI: InChI=1S/C18H18FN3O4S2/c1-18(2,3)15-21-22(17(24)26-15)12-9-11-13(8-10(12)19)28-16(20-11)27-7-5-6-14(23)25-4/h5-6,8-9H,7H2,1-4H3/b6-5+
Standard InChI Key: HVIAOXAHSJYMKX-AATRIKPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 423.49 | Molecular Weight (Monoisotopic): 423.0723 | AlogP: 3.69 | #Rotatable Bonds: 5 |
Polar Surface Area: 87.22 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.67 | CX LogP: 5.52 | CX LogD: 5.52 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.35 | Np Likeness Score: -1.38 |
1. Jiang LL, Tan Y, Zhu XL, Wang ZF, Zuo Y, Chen Q, Xi Z, Yang GF.. (2010) Design, synthesis, and 3D-QSAR analysis of novel 1,3,4-oxadiazol-2(3H)-ones as protoporphyrinogen oxidase inhibitors., 58 (5): [PMID:19954223] [10.1021/jf9026298] |
Source(1):